The Medical Device Authority (MDA) has announced a public consultation on updated Third Edition draft guidance documents (MDA/GD/0068 and MDA/GD/0070) to obtain stakeholder feedback on the proposed verification pathway guidelines.
The updated drafts are:
- MDA/GD/0068 – Conformity Assessment Body (CAB) Guide for Conducting Conformity Assessment by Way of Verification (PDF)
- MDA/GD/0070 – Establishment Guide to Medical Device Registration Submission in MeDC@St Through Conformity Assessment by Way of Verification Process (PDF)
The revisions provide an indication of MDA’s proposed approach to conformity assessment, registration submissions, Quality Management System documentation, technical evidence, and applicable fees under the verification pathway.
Read the MDA announcement here:
https://portal.mda.gov.my/index.php/announcement/1865-announcement-public-consultation-on-updated-draft-guidance-documents-third-edition
Purpose of the Draft Update
To propose revisions to the verification pathway guidance for Conformity Assessment Bodies and establishments in Malaysia, and to gather stakeholder feedback.
The proposed changes also align the guidance with MDA Circular Letter No. 2 of 2025: Conformity Assessment Procedures for Medical Devices Approved by Recognised Countries.
Key Updates to MDA/GD/0068
Conformity Assessment Body Guide for Conducting Conformity Assessment by Way of Verification
| Section | Proposed Change |
|---|---|
| Introduction | Updated to refer to MDA Circular Letter No. 2 of 2025. |
| Scope and Application | Updated to refer to MDA Circular Letter No. 2 of 2025. |
| Conformity Assessment Procedure | Updated to refer to MDA Circular Letter No. 2 of 2025. |
| Appendix 2: Conformity Assessment Elements Review and Verification Criteria for Class B, C and D Initial Certification and Recertification | Adds a statement stating that pre-clinical studies should be conducted in accredited laboratories. A note is also added stating that clinical performance studies for in-vitro medical devices should be conducted in accredited laboratories. |
Key Updates to MDA/GD/0070
Establishment Guide to Medical Device Registration Submission in MeDC@St Through Conformity Assessment by Way of Verification
| Section | Proposed Change |
|---|---|
| Introduction | Updated to refer to MDA Circular Letter No. 2 of 2025. |
| Scope and Application | Updated to refer to MDA Circular Letter No. 2 of 2025. |
| Conformity Assessment Procedure / MeDC@St for New and Re-Registration Applications | Updated to refer to MDA Circular Letter No. 2 of 2025. |
| Table of Fees | Adds application and registration fees for Class A medical devices. |
| Class A Medical Device Registration Application in MeDC@St for New and Re-Registration Application | Under Section 6 (Manufacturer Information), provide updated copies of the legal manufacturer’s ISO 13485 certificates or updated documentation for another acceptable quality management system (QMS). Acceptable alternatives include MDSAP, US FDA Quality Systems Regulations and Japan MHLW Ordinance 169. ISO 9001 is acceptable only for a Class A empty gas cylinder. |
| Annex 4: Class B, C and D Verification Submission Guide | Pre-clinical studies should be conducted in the accredited laboratories in Section 4 Common Submission Dossier Template (CSDT) (Pre-clinical Studies) Note: Clinical performances should be conducted in the accredited laboratories in Section 4: Common Submission Dossier Template (CSDT).(Clinical performance for in-vitro medical devices) |
Included Application and Registration Fees for Class A Medical Device
| Class | Application Fee (RM) | Registration Fee (RM) |
|---|---|---|
| Class A | 500 | 750 |
| Class B | 250 | 1,000 |
| Class C | 500 | 2,000 |
| Class D | 700 | 3,000 |
| Class A medical device containing a medicinal product | 700 | 5,000 |
Applicable Laws and Regulations
The draft guidance documents should be read together with:
- Medical Device Act 2012 (Act 737)
- Medical Device Regulations 2012
- MDA Circular Letter No. 2 of 2025: Conformity Assessment Procedures for Medical Devices Approved by Recognised Countries
Implications to Clients
Manufacturers, Authorized Representatives, importers, distributors and CABs are encouraged to review how the proposed changes may affect their current or planned registration projects and submit any relevant feedback to MDA during the public consultation period.
Effective Date
To be announced upon final issuance of the guidance documents.
For Inquiries
For inquiries or support regarding medical device regulatory requirements in Malaysia, please contact sales@andamanmed.com.
